US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Exelixis

57.43

-0.9000-1.54%

Post-market: 57.430.00000.00%19:06 EDT

Volume:1.79M

Turnover:103.04M

Market Cap:14.23B

PE:18.06

High:58.33

Open:58.33

Low:57.23

Close:58.33

52wk High:59.72

52wk Low:33.76

Shares:247.78M

Float Shares:214.00M

Volume Ratio:0.82

T/O Rate:0.84%

Dividend:- -

Dividend Rate:- -

EPS(TTM):3.18

EPS(LYR):2.78

ROE:44.39%

ROA:23.97%

PB:7.72

PE(LYR):20.66

Loading ...

Overview Company News Filings

Exelixis - Cabometyx Reduces Risk of Progression or Death by 74% in Non-Functional Net, 60% in Functional Net

THOMSON REUTERS

Exelixis Shareholders Approve Equity Plan and Board Slate

Exelixis shareholders approve amended, restated 2017 equity incentive plan at annual meeting

Top Exelixis Insider Makes a Major Move With Company Stock

Exelixis EVP R&D Aftab Dana disposes of 43,451 common shares for $2.19 million

Movement Alert｜Exelixis Rises 5.54% in Regular Trading, Trading at $52.88

Exelixis (EXEL) Valuation Check After ASCO 2026 Data Spotlight And New Merck Trial Collaboration

Simply Wall St.

Exelixis to webcast investor conference fireside chats in June

Exelixis EVP Commercial Patrick J. Haley sells 32,110 shares for $1.6 million

Exelixis to present Cabometyx, zanzalintinib studies at ASCO annual meeting

How Investors May Respond To Exelixis (EXEL) Merck MRD+ Colorectal Cancer Trial Collaboration

Simply Wall St.

Top Exelixis Executive Cashes In on Major Stock Sale

Exelixis EVP, CFO Christopher Senner disposes 75,793 shares for $3.78 million

Exelixis SVP, General Counsel Brenda Hefti disposes 13,036 shares worth $662,202.55

Merck to Collaborate With Exelixis on Phase 3 Colorectal Cancer Trial

MT Newswires Live

Exelixis partners with Merck on phase 3 colorectal cancer trial combining zanzalintinib, Keytruda Qlex

Exelixis Inc - Expects to Initiate Stellar-316 in Mid-2026

THOMSON REUTERS

Exelixis Inc - Merck to Supply Keytruda Qlex for Stellar-316 Trial

THOMSON REUTERS

Exelixis Announces Clinical Development Collaboration With Merck for Phase 3 Stellar-316 Pivotal Trial for Patients With Colorectal Cancer

THOMSON REUTERS

Exelixis Advances Zanzalintinib Into Phase 2 Meningioma Trial, Signaling Pipeline Expansion

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/EXEL/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"EXEL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXEL\",,,,,undefined,":{"symbol":"EXEL","market":"US","secType":"STK","nameCN":"Exelixis","latestPrice":57.43,"timestamp":1789070400000,"preClose":58.33,"halted":0,"volume":1789570,"hourTrading":{"tag":"盘后","latestPrice":57.43,"preClose":57.43,"latestTime":"19:06 EDT","volume":192157,"amount":11035467.364823999,"timestamp":1789081599842,"change":0,"changeRate":0,"amplitude":0.011841},"delay":0,"changeRate":-0.015429453111606354,"floatShares":214000000,"shares":247781692,"eps":3.18,"marketStatus":"Post-Mkt","change":-0.9,"latestTime":"09-10 19:29:21 EDT","open":58.33,"high":58.33,"low":57.23,"amount":103036357.48194,"amplitude":0.018858,"askPrice":57.92,"askSize":17,"bidPrice":56.31,"bidSize":35,"shortable":3,"etf":0,"ttmEps":3.18,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":955425600000,"exchange":"NASDAQ","adjPreClose":58.33,"preHourTrading":{"tag":"盘前","latestPrice":58.51,"preClose":58.33,"latestTime":"09:28 EDT","volume":1894,"amount":110832.913964,"timestamp":1789046880024,"change":0.18,"changeRate":0.003086,"amplitude":0.066518},"postHourTrading":{"tag":"盘后","latestPrice":57.43,"preClose":57.43,"latestTime":"19:06 EDT","volume":192157,"amount":11035467.364823999,"timestamp":1789081599842,"change":0,"changeRate":0,"amplitude":0.011841},"volumeRatio":0.822169,"impliedVol":0.4005,"impliedVolPercentile":0.5896},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXEL\",,,,,undefined,":{"symbol":"EXEL","floatShares":214000000,"roa":"23.97%","roe":"44.39%","lyrEps":2.78,"volumeRatio":0.822169,"shares":247781692,"dividePrice":0,"high":58.33,"amplitude":0.018858,"preClose":58.33,"low":57.23,"week52Low":33.755,"pbRate":"7.72","psRate":"5.84","week52High":59.72,"institutionHeld":0.8319,"latestPrice":57.43,"committee":0.346154,"eps":3.18,"divideRate":0,"volume":1789570,"delay":0,"ttmEps":3.18,"open":58.33,"prevYearClose":43.83,"prevWeekClose":59.01,"prevMonthClose":54.64,"prevQuarterClose":54.41,"fiveDayClose":58.53,"twentyDayClose":50.38,"sixtyDayClose":53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EXEL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"EXEL","fiscalQuarterEnding":"2026/06","expectedEps":0.75,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":0.82},{"market":"US","date":"2026-05-05","symbol":"EXEL","fiscalQuarterEnding":"2026/03","expectedEps":0.67,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":0.79},{"market":"US","date":"2026-02-10","symbol":"EXEL","fiscalQuarterEnding":"2025/12","expectedEps":0.68,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1770699600000,"reportTimeType":"post","actualEps":0.48},{"market":"US","date":"2026-01-11","symbol":"EXEL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1768107600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-04","symbol":"EXEL","fiscalQuarterEnding":"2025/09","expectedEps":0.59,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":0.67}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EXEL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EXEL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1,"buy":0.25,"hold":0.6,"sell":0.05,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6,"analysts":20,"updateTime":1787112000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EXEL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EXEL","date":"2026-09-09","current":18.059748,"percent":0.122565,"low":13.520237,"twenty":17.29642,"median":21.590108,"eighty":34.881998,"high":81.497549,"avg":28.511337,"sd":15.654716,"marketCap":14289570177},"quantilePoints":[{"date":"2021-09-10","current":66.868428,"twenty":-27.329077,"median":15.002715,"eighty":41.184268,"marketCap":6288373808},{"date":"2021-09-17","current":69.41452,"twenty":-27.329077,"median":15.270884,"eighty":41.645802,"marketCap":6527810887},{"date":"2021-09-24","current":68.174975,"twenty":-27.329077,"median":15.454005,"eighty":42.220717,"marketCap":6411242835},{"date":"2021-10-01","current":72.16162,"twenty":-27.329077,"median":15.627908,"eighty":42.663031,"marketCap":6786150893},{"date":"2021-10-08","current":72.42963,"twenty":-27.329077,"median":15.773963,"eighty":43.366777,"marketCap":6811354796},{"date":"2021-10-15","current":73.099654,"twenty":-27.329077,"median":15.952475,"eighty":44.822559,"marketCap":6874364554},{"date":"2021-10-22","current":71.692603,"twenty":-27.329077,"median":16.00116,"eighty":45.312226,"marketCap":6742044063},{"date":"2021-10-29","current":72.061116,"twenty":-27.329077,"median":16.265432,"eighty":45.826118,"marketCap":6776699429},{"date":"2021-11-05","current":37.285528,"twenty":-27.329077,"median":16.391679,"eighty":45.919924,"marketCap":6125452889},{"date":"2021-11-12","current":34.858887,"twenty":-27.329077,"median":16.479897,"eighty":45.919924,"marketCap":5726792216},{"date":"2021-11-19","current":34.724073,"twenty":-27.329077,"median":16.682751,"eighty":45.919924,"marketCap":5704644400},{"date":"2021-11-26","current":32.855945,"twenty":-27.200425,"median":16.81027,"eighty":45.919924,"marketCap":5397738961},{"date":"2021-12-03","current":30.506341,"twenty":-26.943119,"median":16.933764,"eighty":45.919924,"marketCap":5011734182},{"date":"2021-12-10","current":32.066324,"twenty":-26.245177,"median":17.104522,"eighty":45.919924,"marketCap":5268016044},{"date":"2021-12-17","current":35.051477,"twenty":-24.694911,"median":17.218287,"eighty":45.919924,"marketCap":5758431952},{"date":"2021-12-23","current":37.131455,"twenty":-24.254275,"median":17.32582,"eighty":45.919924,"marketCap":6100141100},{"date":"2021-12-31","current":35.20555,"twenty":7.517288,"median":17.464132,"eighty":45.919924,"marketCap":5783743740},{"date":"2022-01-07","current":36.091466,"twenty":7.709485,"median":17.687208,"eighty":45.891374,"marketCap":5929286526},{"date":"2022-01-14","current":34.897405,"twenty":7.799575,"median":17.756166,"eighty":45.891374,"marketCap":5733120163},{"date":"2022-01-21","current":33.356681,"twenty":7.907699,"median":17.862859,"eighty":45.891374,"marketCap":5480002275},{"date":"2022-01-28","current":34.223338,"twenty":7.943549,"median":18.081923,"eighty":45.891374,"marketCap":5622381087},{"date":"2022-02-04","current":36.187761,"twenty":8.039903,"median":18.360975,"eighty":45.891374,"marketCap":5945106394},{"date":"2022-02-11","current":36.110725,"twenty":8.136529,"median":18.515656,"eighty":45.891374,"marketCap":5932450500},{"date":"2022-02-18","current":27.042003,"twenty":8.217909,"median":18.789229,"eighty":45.891374,"marketCap":6248406283},{"date":"2022-02-25","current":27.899162,"twenty":8.270506,"median":18.897922,"eighty":45.891374,"marketCap":6446464151},{"date":"2022-03-04","current":28.61807,"twenty":8.371042,"median":19.106053,"eighty":45.891374,"marketCap":6612577201},{"date":"2022-03-11","current":29.019,"twenty":8.507031,"median":19.335948,"eighty":45.891374,"marketCap":6705217172},{"date":"2022-03-18","current":29.572006,"twenty":8.621808,"median":21.199768,"eighty":45.891374,"marketCap":6832996441},{"date":"2022-03-25","current":30.249439,"twenty":8.73225,"median":22.506564,"eighty":45.891374,"marketCap":6989526047},{"date":"2022-04-01","current":31.645779,"twenty":8.756029,"median":22.697854,"eighty":45.891374,"marketCap":7312168702},{"date":"2022-04-08","current":31.825506,"twenty":8.792498,"median":22.852188,"eighty":45.891374,"marketCap":7353696965},{"date":"2022-04-14","current":31.995647,"twenty":8.865935,"median":22.952956,"eighty":45.891374,"marketCap":7393010230},{"date":"2022-04-22","current":31.067233,"twenty":8.939729,"median":23.213643,"eighty":45.891374,"marketCap":7178488062},{"date":"2022-04-29","current":30.956378,"twenty":8.974263,"median":23.420305,"eighty":45.891374,"marketCap":7152873475},{"date":"2022-05-06","current":29.778539,"twenty":9.039592,"median":23.531551,"eighty":45.891374,"marketCap":6880718486},{"date":"2022-05-13","current":21.60979,"twenty":9.09473,"median":23.549925,"eighty":45.891374,"marketCap":6440473677},{"date":"2022-05-20","current":19.113041,"twenty":9.107191,"median":23.549925,"eighty":45.891374,"marketCap":5696355204},{"date":"2022-05-27","current":19.801799,"twenty":9.125872,"median":23.549925,"eighty":45.891374,"marketCap":5901629266},{"date":"2022-06-03","current":20.490558,"twenty":9.145972,"median":23.549925,"eighty":45.891374,"marketCap":6106903327},{"date":"2022-06-10","current":19.521991,"twenty":9.183299,"median":23.549925,"eighty":45.891374,"marketCap":5818236678},{"date":"2022-06-17","current":19.973989,"twenty":9.197529,"median":23.549925,"eighty":45.891374,"marketCap":5952947781},{"date":"2022-06-24","current":23.912825,"twenty":9.237499,"median":23.564333,"eighty":45.919924,"marketCap":7126858820},{"date":"2022-07-01","current":23.213305,"twenty":9.247736,"median":23.584442,"eighty":45.919924,"marketCap":6918377351},{"date":"2022-07-08","current":23.686826,"twenty":9.281845,"median":23.611294,"eighty":45.919924,"marketCap":7059503269},{"date":"2022-07-15","current":22.965782,"twenty":9.328108,"median":23.611294,"eighty":45.919924,"marketCap":6844606986},{"date":"2022-07-22","current":22.449214,"twenty":9.353834,"median":23.633017,"eighty":45.919924,"marketCap":6690651440},{"date":"2022-07-29","current":22.513785,"twenty":9.38718,"median":23.633017,"eighty":45.919924,"marketCap":6709895883},{"date":"2022-08-05","current":23.159496,"twenty":9.423477,"median":23.633017,"eighty":45.919924,"marketCap":6902340315},{"date":"2022-08-12","current":22.996839,"twenty":9.477679,"median":23.677084,"eighty":45.919924,"marketCap":6269283152},{"date":"2022-08-19","current":22.819758,"twenty":9.532448,"median":23.677084,"eighty":45.919924,"marketCap":6221008384},{"date":"2022-08-26","current":21.521169,"twenty":9.589879,"median":23.677084,"eighty":45.919924,"marketCap":5866993422},{"date":"2022-09-02","current":21.143397,"twenty":9.637235,"median":23.677084,"eighty":45.919924,"marketCap":5764007251},{"date":"2022-09-09","current":21.131592,"twenty":9.656291,"median":23.677084,"eighty":45.919924,"marketCap":5760788933},{"date":"2022-09-16","current":20.24619,"twenty":9.709392,"median":23.677084,"eighty":45.919924,"marketCap":5519415095},{"date":"2022-09-23","current":19.219124,"twenty":9.737158,"median":23.677084,"eighty":45.919924,"marketCap":5239421443},{"date":"2022-09-30","current":18.510802,"twenty":9.752596,"median":23.677084,"eighty":45.919924,"marketCap":5046322373},{"date":"2022-10-07","current":18.180252,"twenty":9.809283,"median":23.677084,"eighty":45.919924,"marketCap":4956209473},{"date":"2022-10-14","current":18.475386,"twenty":9.839263,"median":23.677084,"eighty":45.919924,"marketCap":5036667419},{"date":"2022-10-21","current":19.419815,"twenty":9.921087,"median":23.677084,"eighty":45.919924,"marketCap":5294132846},{"date":"2022-10-28","current":19.632311,"twenty":9.95111,"median":23.677084,"eighty":45.919924,"marketCap":5352062567},{"date":"2022-11-04","current":17.259423,"twenty":9.977849,"median":23.677084,"eighty":45.919924,"marketCap":5309360940},{"date":"2022-11-11","current":17.615936,"twenty":10.045835,"median":23.677084,"eighty":45.919924,"marketCap":5419031822},{"date":"2022-11-18","current":17.731278,"twenty":10.09551,"median":23.677084,"eighty":45.919924,"marketCap":5454513578},{"date":"2022-11-25","current":17.762735,"twenty":10.137764,"median":23.677084,"eighty":45.919924,"marketCap":5464190420},{"date":"2022-12-02","current":18.234591,"twenty":10.262522,"median":23.677084,"eighty":45.919924,"marketCap":5609343059},{"date":"2022-12-09","current":16.535911,"twenty":10.306552,"median":23.677084,"eighty":45.919924,"marketCap":5086793561},{"date":"2022-12-16","current":16.714168,"twenty":10.501618,"median":23.677084,"eighty":45.919924,"marketCap":5141629002},{"date":"2022-12-23","current":16.598825,"twenty":10.590509,"median":23.677084,"eighty":45.919924,"marketCap":5106147246},{"date":"2022-12-30","current":16.819025,"twenty":10.667114,"median":23.677084,"eighty":45.919924,"marketCap":5173885144},{"date":"2023-01-06","current":18.108763,"twenty":10.667114,"median":23.584442,"eighty":45.49168,"marketCap":5570635688},{"date":"2023-01-13","current":17.227966,"twenty":10.667114,"median":23.503875,"eighty":45.1654,"marketCap":5299684097},{"date":"2023-01-20","current":17.542536,"twenty":10.667114,"median":23.449537,"eighty":44.010071,"marketCap":5396452523},{"date":"2023-01-27","current":18.318476,"twenty":10.667114,"median":23.314972,"eighty":43.020435,"marketCap":5635147972},{"date":"2023-02-03","current":18.402362,"twenty":10.667114,"median":23.194326,"eighty":42.458135,"marketCap":5660952885},{"date":"2023-02-10","current":31.202932,"twenty":10.667114,"median":23.191781,"eighty":42.011762,"marketCap":5687732764},{"date":"2023-02-17","current":31.096255,"twenty":10.667114,"median":23.191781,"eighty":41.420955,"marketCap":5668287524},{"date":"2023-02-24","current":30.456195,"twenty":10.667114,"median":23.191781,"eighty":41.184268,"marketCap":5551616082},{"date":"2023-03-03","current":30.491754,"twenty":10.667114,"median":23.191781,"eighty":40.984929,"marketCap":5558097829},{"date":"2023-03-10","current":29.65612,"twenty":10.667114,"median":23.191781,"eighty":40.686627,"marketCap":5405776781},{"date":"2023-03-17","current":31.202932,"twenty":10.667114,"median":23.191781,"eighty":40.243946,"marketCap":5687732764},{"date":"2023-03-24","current":32.85642,"twenty":10.667114,"median":23.191781,"eighty":39.955417,"marketCap":5989133987},{"date":"2023-03-31","current":34.509909,"twenty":10.667928,"median":23.193053,"eighty":39.475483,"marketCap":6290535211},{"date":"2023-04-06","current":35.363322,"twenty":10.667928,"median":23.193053,"eighty":39.271956,"marketCap":6446097132},{"date":"2023-04-14","current":34.918836,"twenty":10.667114,"median":23.191781,"eighty":39.023166,"marketCap":6365075298},{"date":"2023-04-21","current":33.620936,"twenty":10.667114,"median":23.191781,"eighty":38.427704,"marketCap":6128491542},{"date":"2023-04-28","current":32.305257,"twenty":10.667114,"median":23.191781,"eighty":37.395181,"marketCap":5888666913},{"date":"2023-05-05","current":34.73643,"twenty":10.667114,"median":23.191781,"eighty":37.193084,"marketCap":6331825854},{"date":"2023-05-12","current":40.911234,"twenty":10.667114,"median":23.213305,"eighty":37.526354,"marketCap":6289570343},{"date":"2023-05-19","current":41.790934,"twenty":10.666299,"median":23.203815,"eighty":38.431783,"marketCap":6424812840},{"date":"2023-05-26","current":40.308235,"twenty":10.666299,"median":23.203815,"eighty":39.03948,"marketCap":6196867124},{"date":"2023-05-31","current":40.265872,"twenty":10.666299,"median":23.203815,"eighty":39.188346,"marketCap":6190354389},{"date":"2023-06-09","current":40.98604,"twenty":10.659474,"median":23.193053,"eighty":39.394311,"marketCap":6301070880},{"date":"2023-06-16","current":40.456505,"twenty":10.636307,"median":23.23296,"eighty":39.77769,"marketCap":6219661695},{"date":"2023-06-22","current":40.265872,"twenty":10.614439,"median":23.277876,"eighty":40.236218,"marketCap":6190354389},{"date":"2023-06-26","current":42.066293,"twenty":10.603505,"median":23.311527,"eighty":40.265872,"marketCap":6467145616},{"date":"2023-07-07","current":40.943677,"twenty":10.600095,"median":23.213305,"eighty":40.520035,"marketCap":6294558145},{"date":"2023-07-14","current":40.98604,"twenty":10.600095,"median":23.213305,"eighty":40.545455,"marketCap":6301070880},{"date":"2023-07-21","current":42.087474,"twenty":10.600095,"median":23.213305,"eighty":40.680159,"marketCap":6470401984},{"date":"2023-07-28","current":41.515576,"twenty":10.600095,"median":23.213305,"eighty":40.924511,"marketCap":6382480064},{"date":"2023-08-04","current":40.24272,"twenty":10.600095,"median":23.354574,"eighty":40.932036,"marketCap":6609585096},{"date":"2023-08-11","current":40.998725,"twenty":10.600095,"median":23.481924,"eighty":40.941559,"marketCap":6733753602},{"date":"2023-08-18","current":40.707954,"twenty":10.600095,"median":23.579987,"eighty":40.983764,"marketCap":6685996485},{"date":"2023-08-25","current":42.161809,"twenty":10.600095,"median":23.703849,"eighty":41.024602,"marketCap":6924782073},{"date":"2023-09-01","current":43.402433,"twenty":10.600095,"median":23.784876,"eighty":41.205168,"marketCap":7128545776},{"date":"2023-09-08","current":42.685197,"twenty":10.600095,"median":23.881479,"eighty":41.417849,"marketCap":7010744885},{"date":"2023-09-15","current":43.169816,"twenty":10.600095,"median":23.959006,"eighty":41.704282,"marketCap":7090340081},{"date":"2023-09-22","current":41.832269,"twenty":10.600095,"median":24.063445,"eighty":41.742049,"marketCap":6870657340},{"date":"2023-09-29","current":43.402433,"twenty":10.600095,"median":24.159779,"eighty":41.859163,"marketCap":7128545776},{"date":"2023-10-06","current":42.917814,"twenty":10.600095,"median":24.411169,"eighty":41.925256,"marketCap":7048950579},{"date":"2023-10-13","current":41.173188,"twenty":10.600095,"median":24.472259,"eighty":41.970666,"marketCap":6762407873},{"date":"2023-10-20","current":40.378413,"twenty":10.600095,"median":24.601456,"eighty":42.032402,"marketCap":6631871751},{"date":"2023-10-27","current":40.688569,"twenty":10.590509,"median":24.763289,"eighty":42.053584,"marketCap":6682812677},{"date":"2023-11-03","current":67.987802,"twenty":10.590509,"median":24.82708,"eighty":42.104419,"marketCap":6259908894},{"date":"2023-11-10","current":70.993721,"twenty":10.590509,"median":24.916894,"eighty":42.169563,"marketCap":6536675855},{"date":"2023-11-17","current":70.858623,"twenty":10.590509,"median":25.114925,"eighty":42.251018,"marketCap":6524236890},{"date":"2023-11-24","current":73.222829,"twenty":10.590509,"median":25.234082,"eighty":42.431195,"marketCap":6741918769},{"date":"2023-12-01","current":73.661896,"twenty":10.590509,"median":25.380185,"eighty":42.822269,"marketCap":6782345404},{"date":"2023-12-08","current":74.269835,"twenty":10.594875,"median":25.475549,"eighty":42.99923,"marketCap":6838320744},{"date":"2023-12-15","current":78.728051,"twenty":10.594875,"median":25.683605,"eighty":43.169816,"marketCap":7248806574},{"date":"2023-12-22","current":79.302215,"twenty":10.594875,"median":25.809174,"eighty":43.432834,"marketCap":7301672173},{"date":"2023-12-29","current":81.497549,"twenty":10.590509,"median":25.871438,"eighty":43.801759,"marketCap":7503805346},{"date":"2024-01-05","current":79.741282,"twenty":10.586142,"median":26.026128,"eighty":45.173557,"marketCap":7342098807},{"date":"2024-01-12","current":75.688358,"twenty":10.586142,"median":26.123266,"eighty":45.499837,"marketCap":6968929872},{"date":"2024-01-19","current":75.215517,"twenty":10.581776,"median":26.310309,"eighty":46.429737,"marketCap":6925393496},{"date":"2024-01-26","current":74.607578,"twenty":10.586142,"median":26.757641,"eighty":47.070063,"marketCap":6869418156},{"date":"2024-02-02","current":73.45925,"twenty":10.586142,"median":26.8819,"eighty":48.970648,"marketCap":6763686957},{"date":"2024-02-09","current":29.434352,"twenty":10.586142,"median":27.133306,"eighty":50.736642,"marketCap":6115428204},{"date":"2024-02-16","current":30.047264,"twenty":10.666299,"median":27.737543,"eighty":50.736642,"marketCap":6242769792},{"date":"2024-02-23","current":30.222382,"twenty":10.755729,"median":28.081886,"eighty":50.736642,"marketCap":6279153103},{"date":"2024-03-01","current":31.958965,"twenty":12.580654,"median":28.465994,"eighty":50.389968,"marketCap":6639954272},{"date":"2024-03-08","current":32.236234,"twenty":14.477572,"median":28.687196,"eighty":50.389968,"marketCap":6697561181},{"date":"2024-03-15","current":32.995077,"twenty":15.693391,"median":29.087177,"eighty":50.389968,"marketCap":6855222195},{"date":"2024-03-22","current":34.906778,"twenty":16.21505,"median":29.378454,"eighty":50.389968,"marketCap":7252406675},{"date":"2024-03-28","current":34.819219,"twenty":16.431775,"median":29.448945,"eighty":50.389968,"marketCap":7234215019},{"date":"2024-04-05","current":34.279273,"twenty":16.579951,"median":29.605173,"eighty":50.736642,"marketCap":7122033143},{"date":"2024-04-12","current":33.05345,"twenty":16.813772,"median":29.772048,"eighty":50.736642,"marketCap":6867349966},{"date":"2024-04-19","current":31.911299,"twenty":16.916749,"median":30.058488,"eighty":50.736642,"marketCap":6630050987},{"date":"2024-04-26","current":33.386966,"twenty":17.091652,"median":30.249439,"eighty":50.389968,"marketCap":6936642941},{"date":"2024-05-03","current":31.422916,"twenty":17.176551,"median":30.506341,"eighty":50.389968,"marketCap":6443394612},{"date":"2024-05-10","current":30.911512,"twenty":17.328629,"median":30.882901,"eighty":50.389968,"marketCap":6338529239},{"date":"2024-05-17","current":30.158612,"twenty":17.488992,"median":30.882901,"eighty":50.389968,"marketCap":6184144105},{"date":"2024-05-24","current":28.993748,"twenty":17.580284,"median":30.882901,"eighty":50.389968,"marketCap":5945284088},{"date":"2024-05-31","current":30.812073,"twenty":17.615936,"median":30.882901,"eighty":50.389968,"marketCap":6318138749},{"date":"2024-06-07","current":31.08198,"twenty":17.668364,"median":30.954522,"eighty":50.389968,"marketCap":6373484363},{"date":"2024-06-14","current":30.883101,"twenty":17.731278,"median":31.025137,"eighty":50.389968,"marketCap":6332703384},{"date":"2024-06-21","current":31.536561,"twenty":17.769898,"median":31.042917,"eighty":50.736642,"marketCap":6466698028},{"date":"2024-06-28","current":31.920114,"twenty":17.8613,"median":31.103323,"eighty":50.736642,"marketCap":6545347058},{"date":"2024-07-05","current":31.394505,"twenty":18.024877,"median":31.149457,"eighty":50.736642,"marketCap":6437568758},{"date":"2024-07-12","current":31.820674,"twenty":18.175107,"median":31.199278,"eighty":50.736642,"marketCap":6524956569},{"date":"2024-07-19","current":32.104788,"twenty":18.272126,"median":31.292005,"eighty":50.736642,"marketCap":6583215110},{"date":"2024-07-26","current":33.227035,"twenty":18.414252,"median":31.360962,"eighty":50.736642,"marketCap":6813336346},{"date":"2024-08-02","current":34.335076,"twenty":18.480333,"median":31.430019,"eighty":50.736642,"marketCap":7040544655},{"date":"2024-08-09","current":21.981185,"twenty":18.723299,"median":31.444483,"eighty":50.736642,"marketCap":7693239023},{"date":"2024-08-16","current":21.475871,"twenty":18.914042,"median":31.444483,"eighty":50.736642,"marketCap":7516382953},{"date":"2024-08-23","current":21.09281,"twenty":19.069994,"median":31.444483,"eighty":50.736642,"marketCap":7382314643},{"date":"2024-08-30","current":21.215063,"twenty":19.173593,"median":31.444483,"eighty":50.736642,"marketCap":7425102401},{"date":"2024-09-06","current":20.497842,"twenty":19.271067,"median":31.444483,"eighty":50.736642,"marketCap":7174080883},{"date":"2024-09-13","current":21.565523,"twenty":19.391482,"median":31.444483,"eighty":50.736642,"marketCap":7547760643},{"date":"2024-09-20","current":21.532922,"twenty":19.566201,"median":31.444483,"eighty":50.736642,"marketCap":7536350574},{"date":"2024-09-27","current":21.158012,"twenty":19.756599,"median":31.444483,"eighty":50.736642,"marketCap":7405134781},{"date":"2024-10-04","current":21.728528,"twenty":20.051881,"median":31.444483,"eighty":50.736642,"marketCap":7604810988},{"date":"2024-10-11","current":21.378068,"twenty":20.260356,"median":31.444483,"eighty":50.736642,"marketCap":7482152746},{"date":"2024-10-18","current":23.554181,"twenty":20.577253,"median":31.444483,"eighty":50.736642,"marketCap":8243774852},{"date":"2024-10-25","current":22.714707,"twenty":20.830566,"median":31.444483,"eighty":50.736642,"marketCap":7949965575},{"date":"2024-11-01","current":20.868399,"twenty":20.870141,"median":31.444483,"eighty":50.736642,"marketCap":9743956162},{"date":"2024-11-08","current":22.171145,"twenty":20.970556,"median":31.444483,"eighty":50.736642,"marketCap":10352239475},{"date":"2024-11-15","current":21.070232,"twenty":21.016922,"median":31.444483,"eighty":50.736642,"marketCap":9838197239},{"date":"2024-11-22","current":21.779709,"twenty":21.079263,"median":31.444483,"eighty":50.736642,"marketCap":10169468902},{"date":"2024-11-29","current":22.299584,"twenty":21.136314,"median":31.444483,"eighty":50.736642,"marketCap":10412211069},{"date":"2024-12-06","current":21.908149,"twenty":21.209839,"median":31.444483,"eighty":50.736642,"marketCap":10229440496},{"date":"2024-12-13","current":21.424971,"twenty":21.270039,"median":31.444483,"eighty":50.736642,"marketCap":10003833070},{"date":"2024-12-20","current":20.360756,"twenty":21.286762,"median":31.444483,"eighty":50.736642,"marketCap":9506925575},{"date":"2024-12-27","current":20.678797,"twenty":21.286762,"median":31.444483,"eighty":50.736642,"marketCap":9655426666},{"date":"2025-01-03","current":20.776656,"twenty":21.286762,"median":31.444483,"eighty":50.736642,"marketCap":9701119309},{"date":"2025-01-10","current":22.030472,"twenty":21.317067,"median":31.451844,"eighty":51.083315,"marketCap":10286556300},{"date":"2025-01-17","current":22.140564,"twenty":21.392738,"median":31.451844,"eighty":51.083315,"marketCap":10337960524},{"date":"2025-01-24","current":19.804184,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9247048667},{"date":"2025-01-31","current":20.275129,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9466944513},{"date":"2025-02-07","current":20.476963,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9561185589},{"date":"2025-02-14","current":18.792386,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9795850750},{"date":"2025-02-21","current":19.785698,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":10313631432},{"date":"2025-02-28","current":20.773641,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":10828613300},{"date":"2025-03-07","current":20.714579,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10797826341},{"date":"2025-03-14","current":19.678313,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10257655142},{"date":"2025-03-21","current":19.84476,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10344418392},{"date":"2025-03-28","current":19.705159,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10271649215},{"date":"2025-04-04","current":18.561508,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":9675501726},{"date":"2025-04-11","current":18.958833,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9882613999},{"date":"2025-04-17","current":19.324707,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":10073332113},{"date":"2025-04-25","current":19.986841,"twenty":21.378068,"median":31.451844,"eighty":51.429988,"marketCap":10418480823},{"date":"2025-05-02","current":21.145576,"twenty":21.26595,"median":31.451844,"eighty":51.429988,"marketCap":11022491066},{"date":"2025-05-09","current":19.314028,"twenty":21.215063,"median":31.451844,"eighty":51.429988,"marketCap":10067765198},{"date":"2025-05-16","current":19.238052,"twenty":21.149861,"median":31.451844,"eighty":51.429988,"marketCap":12380955912},{"date":"2025-05-23","current":18.161738,"twenty":21.100813,"median":31.451844,"eighty":51.429988,"marketCap":11688276880},{"date":"2025-05-30","current":18.051564,"twenty":21.052058,"median":31.451844,"eighty":51.429988,"marketCap":11617372728},{"date":"2025-06-06","current":17.954102,"twenty":21.011307,"median":31.451844,"eighty":51.429988,"marketCap":11554649823},{"date":"2025-06-13","current":17.704092,"twenty":20.970556,"median":31.451844,"eighty":51.429988,"marketCap":11393751938},{"date":"2025-06-20","current":17.263397,"twenty":20.919812,"median":31.451844,"eighty":52.534404,"marketCap":11110135327},{"date":"2025-06-27","current":18.259199,"twenty":20.836957,"median":31.451844,"eighty":52.534404,"marketCap":11750999785},{"date":"2025-07-03","current":19.555861,"twenty":20.776053,"median":31.451844,"eighty":52.534404,"marketCap":12585487122},{"date":"2025-07-11","current":19.14059,"twenty":20.723755,"median":31.451844,"eighty":52.534404,"marketCap":12318233007},{"date":"2025-07-18","current":19.013466,"twenty":20.683176,"median":31.451844,"eighty":52.534404,"marketCap":12236420523},{"date":"2025-07-25","current":18.979567,"twenty":20.586623,"median":31.451844,"eighty":52.534404,"marketCap":12214603861},{"date":"2025-08-01","current":16.188856,"twenty":20.513914,"median":31.451844,"eighty":52.534404,"marketCap":9750515310},{"date":"2025-08-08","current":16.711798,"twenty":20.476963,"median":31.451844,"eighty":52.534404,"marketCap":10065482260},{"date":"2025-08-15","current":17.194513,"twenty":20.30571,"median":31.451844,"eighty":52.534404,"marketCap":10356220982},{"date":"2025-08-22","current":17.301783,"twenty":20.251749,"median":31.451844,"eighty":52.534404,"marketCap":10420829587},{"date":"2025-08-29","current":16.939747,"twenty":20.21434,"median":31.451844,"eighty":52.534404,"marketCap":10202775545},{"date":"2025-09-05","current":16.707328,"twenty":20.146713,"median":31.458689,"eighty":53.63882,"marketCap":10062790234},{"date":"2025-09-12","current":17.462689,"twenty":19.984406,"median":31.451844,"eighty":52.534404,"marketCap":10517742495},{"date":"2025-09-19","current":18.079492,"twenty":19.948593,"median":31.451844,"eighty":52.534404,"marketCap":10889241974},{"date":"2025-09-26","current":17.292844,"twenty":19.877101,"median":31.451844,"eighty":52.534404,"marketCap":10415445537},{"date":"2025-10-03","current":18.481755,"twenty":19.840807,"median":31.451844,"eighty":52.534404,"marketCap":11131524243},{"date":"2025-10-10","current":17.239209,"twenty":19.803707,"median":31.451844,"eighty":52.534404,"marketCap":10383141234},{"date":"2025-10-17","current":17.525263,"twenty":19.742534,"median":31.451844,"eighty":52.534404,"marketCap":10555430848},{"date":"2025-10-24","current":17.006791,"twenty":19.679289,"median":31.451844,"eighty":52.534404,"marketCap":10243155924},{"date":"2025-10-31","current":17.404584,"twenty":19.615895,"median":31.451844,"eighty":52.534404,"marketCap":10482746167},{"date":"2025-11-07","current":16.202116,"twenty":19.555861,"median":31.437122,"eighty":52.534404,"marketCap":10983462856},{"date":"2025-11-14","current":16.817637,"twenty":19.509455,"median":31.380299,"eighty":52.534404,"marketCap":11400726764},{"date":"2025-11-21","current":16.591284,"twenty":19.373439,"median":31.295065,"eighty":52.534404,"marketCap":11247281327},{"date":"2025-11-28","current":17.540379,"twenty":19.314266,"median":31.202932,"eighty":52.534404,"marketCap":11890675352},{"date":"2025-12-05","current":17.619801,"twenty":19.287595,"median":31.161149,"eighty":52.534404,"marketCap":11944515856},{"date":"2025-12-12","current":16.436411,"twenty":19.234266,"median":31.110391,"eighty":52.534404,"marketCap":11142292344},{"date":"2025-12-19","current":16.905002,"twenty":19.13508,"median":31.060696,"eighty":52.534404,"marketCap":11459951318},{"date":"2025-12-26","current":18.469618,"twenty":19.091517,"median":30.989578,"eighty":52.534404,"marketCap":12520609251},{"date":"2026-01-02","current":17.405361,"twenty":19.012619,"median":30.926871,"eighty":52.534404,"marketCap":11799146495},{"date":"2026-01-09","current":17.532437,"twenty":18.97458,"median":30.882901,"eighty":52.534404,"marketCap":11885291302},{"date":"2026-01-16","current":18.044709,"twenty":18.899845,"median":30.670016,"eighty":50.234126,"marketCap":12232562554},{"date":"2026-01-23","current":17.671425,"twenty":18.838561,"median":30.491754,"eighty":50.234126,"marketCap":11979512184},{"date":"2026-01-30","current":16.78984,"twenty":18.766673,"median":30.249439,"eighty":50.234126,"marketCap":11381882587},{"date":"2026-02-06","current":16.825579,"twenty":18.695068,"median":30.105636,"eighty":50.234126,"marketCap":11406110814},{"date":"2026-02-13","current":14.170695,"twenty":18.554438,"median":29.889985,"eighty":43.40631,"marketCap":11089561020},{"date":"2026-02-20","current":14.65522,"twenty":18.504467,"median":29.831882,"eighty":43.092277,"marketCap":11468735706},{"date":"2026-02-27","current":14.695044,"twenty":18.475686,"median":29.755401,"eighty":42.964338,"marketCap":11499900748},{"date":"2026-03-06","current":13.699445,"twenty":18.456655,"median":29.521911,"eighty":42.638674,"marketCap":10720774681},{"date":"2026-03-13","current":13.66294,"twenty":18.41075,"median":29.44758,"eighty":42.285872,"marketCap":10692206726},{"date":"2026-03-20","current":13.692808,"twenty":18.342542,"median":29.115776,"eighty":42.161809,"marketCap":10715580508},{"date":"2026-03-27","current":14.057861,"twenty":18.259199,"median":28.993748,"eighty":42.049347,"marketCap":11001260066},{"date":"2026-04-02","current":14.615396,"twenty":18.234428,"median":28.687196,"eighty":41.878613,"marketCap":11437570663},{"date":"2026-04-10","current":15.070053,"twenty":18.171384,"median":28.383043,"eighty":41.791447,"marketCap":11793371567},{"date":"2026-04-17","current":14.728231,"twenty":18.108763,"median":27.097303,"eighty":41.696576,"marketCap":11525871617},{"date":"2026-04-24","current":14.947003,"twenty":18.071285,"median":24.862085,"eighty":41.545375,"marketCap":11697076412},{"date":"2026-05-01","current":14.430918,"twenty":18.014311,"median":23.686826,"eighty":41.386833,"marketCap":11293203416},{"date":"2026-05-08","current":13.936676,"twenty":17.953577,"median":23.497129,"eighty":41.036876,"marketCap":11615118385},{"date":"2026-05-15","current":15.411472,"twenty":17.905982,"median":23.228171,"eighty":40.949874,"marketCap":12844244741},{"date":"2026-05-22","current":14.974161,"twenty":17.865495,"median":23.159496,"eighty":40.903688,"marketCap":12479779870},{"date":"2026-05-29","current":15.51703,"twenty":17.794093,"median":23.031304,"eighty":40.696323,"marketCap":12932219020},{"date":"2026-06-05","current":15.830689,"twenty":17.72762,"median":22.976544,"eighty":40.649215,"marketCap":13193628306},{"date":"2026-06-12","current":16.135299,"twenty":17.677365,"median":22.910312,"eighty":40.520049,"marketCap":13447496940},{"date":"2026-06-18","current":15.815609,"twenty":17.660523,"median":22.794995,"eighty":40.339215,"marketCap":13181060552},{"date":"2026-06-26","current":16.053868,"twenty":17.618489,"median":22.608952,"eighty":40.029841,"marketCap":13379631068},{"date":"2026-07-02","current":16.274032,"twenty":17.615894,"median":22.524547,"eighty":39.347145,"marketCap":13563120278},{"date":"2026-07-10","current":17.221039,"twenty":17.587238,"median":22.397431,"eighty":37.962212,"marketCap":14352375239},{"date":"2026-07-17","current":16.792775,"twenty":17.541673,"median":22.296526,"eighty":36.938865,"marketCap":13995451021},{"date":"2026-07-24","current":16.783727,"twenty":17.523027,"median":22.203786,"eighty":36.596054,"marketCap":13987910368},{"date":"2026-07-31","current":16.880237,"twenty":17.497396,"median":22.134447,"eighty":36.439357,"marketCap":14068343995},{"date":"2026-08-07","current":15.028885,"twenty":17.477953,"median":21.975427,"eighty":36.110725,"marketCap":12934204322},{"date":"2026-08-14","current":14.571109,"twenty":17.441235,"median":21.877568,"eighty":35.783336,"marketCap":12540231432},{"date":"2026-08-21","current":15.457871,"twenty":17.393,"median":21.779709,"eighty":35.430434,"marketCap":13303399043},{"date":"2026-08-28","current":15.909889,"twenty":17.338011,"median":21.718547,"eighty":35.186291,"marketCap":13692416299},{"date":"2026-09-04","current":17.024099,"twenty":17.306151,"median":21.60979,"eighty":34.914013,"marketCap":14651331447},{"date":"2026-09-09","current":16.603751,"twenty":17.29642,"median":21.590108,"eighty":34.881998,"marketCap":14289570177}],"updateTime":1789082961958},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EXEL\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2639609492","title":"Exelixis - Cabometyx Reduces Risk of Progression or Death by 74% in Non-Functional Net, 60% in Functional Net","url":"https://stock-news.laohu8.com/highlight/detail?id=2639609492","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639609492?lang=en_us&edition=fundamental","pubTime":"2026-05-30 22:03","pubTimestamp":1780149802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nFWN4261DX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","BK4139","EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639777016","title":"Exelixis Shareholders Approve Equity Plan and Board Slate","url":"https://stock-news.laohu8.com/highlight/detail?id=2639777016","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639777016?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:48","pubTimestamp":1780087687,"startTime":"0","endTime":"0","summary":"Exelixis ( ($EXEL) ) has shared an update. On May 26, 2026, Exelixis held its annual meeting of stockholders via live webcast, where shareholders a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/exelixis-shareholders-approve-equity-plan-and-board-slate?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/exelixis-shareholders-approve-equity-plan-and-board-slate?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4215","BK4585","BK4532","EQR","EXEL","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639672769","title":"Exelixis shareholders approve amended, restated 2017 equity incentive plan at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639672769","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639672769?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:10","pubTimestamp":1780085449,"startTime":"0","endTime":"0","summary":"Exelixis held its annual stockholder meeting on May 26, 2026.Shareholders authorized an amended and restated 2017 Equity Incentive Plan, effective immediately upon the vote; no implementation actions were detailed.Ernst & Young was ratified as independent registered public accounting firm for the fiscal year ending Jan. 1, 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL2KlxNb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4532","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639643859","title":"Top Exelixis Insider Makes a Major Move With Company Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2639643859","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639643859?lang=en_us&edition=fundamental","pubTime":"2026-05-29 10:15","pubTimestamp":1780020938,"startTime":"0","endTime":"0","summary":"New insider activity at Exelixis ( ($EXEL) ) has taken place on May 28, 2026. Exelixis’ Executive Vice President of Research and Development, Aftab...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-exelixis-insider-makes-a-major-move-with-company-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-exelixis-insider-makes-a-major-move-with-company-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4532","EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639614366","title":"Exelixis EVP R&D Aftab Dana disposes of 43,451 common shares for $2.19 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2639614366","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639614366?lang=en_us&edition=fundamental","pubTime":"2026-05-29 06:25","pubTimestamp":1780007154,"startTime":"0","endTime":"0","summary":"Exelixis EVP, Research and Development Aftab Dana sold 43,451 common shares on May 26, 2026 at USD 50.35.Directly held stake fell to 594,741 shares following the transaction.Indirect holdings included 5,835 shares in a 401 plan as of May 26, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 28, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL997Wl5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Exelixis EVP R&D Aftab Dana disposes of 43,451 common shares for $2.19 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4139","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111683139","title":"Movement Alert｜Exelixis Rises 5.54% in Regular Trading, Trading at $52.88","url":"https://stock-news.laohu8.com/highlight/detail?id=1111683139","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111683139?lang=en_us&edition=fundamental","pubTime":"2026-05-29 00:16","pubTimestamp":1779984972,"startTime":"0","endTime":"0","summary":"On May 28, Exelixis rose 5.54% in regular trading, trading at $52.88 USD/share, with trading volume of $61.21 million.Within the Biotechnology sector where Exelixis belongs, individual stock...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638654507","title":"Exelixis (EXEL) Valuation Check After ASCO 2026 Data Spotlight And New Merck Trial Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2638654507","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638654507?lang=en_us&edition=fundamental","pubTime":"2026-05-28 12:38","pubTimestamp":1779943086,"startTime":"0","endTime":"0","summary":"Exelixis (EXEL) has put fresh attention on its oncology pipeline after announcing extensive CABOMETYX and zanzalintinib data presentations at the 2026 ASCO meeting, along with a new colorectal cancer trial collaboration with Merck.\nSee our latest analysis for Exelixis.\nThe recent ASCO spotlight and Merck collaboration come after a strong run in the stock, with a 30 day share price return of 12.05% and a 3 year total shareholder return of 159.49%. This suggests that momentum has been building...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/exelixis-exel-valuation-check-after-asco-2026-data-spotlight","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/exelixis-exel-valuation-check-after-asco-2026-data-spotlight","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","EXEL","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638964635","title":"Exelixis to webcast investor conference fireside chats in June","url":"https://stock-news.laohu8.com/highlight/detail?id=2638964635","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638964635?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:06","pubTimestamp":1779912392,"startTime":"0","endTime":"0","summary":"Exelixis management will join a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL4d22wl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0096364046.USD","LU1668664300.SGD","LU0742534661.SGD","BK4504","IE00B19Z3B42.SGD","LU1894683348.USD","LU1894683264.USD","LU1868836757.USD","LU2237443978.SGD","BK4550","LU0048573561.USD","EXEL","IE0004091025.USD","LU2237443382.USD","LU2237443622.USD","LU2471134796.USD","LU2750360641.GBP","IE00B19Z3581.USD","LU0061475181.USD","LU2237438978.USD","BK4588","LU1868837300.USD","LU2265009873.SGD","GSX","BK4585","LU1791807156.HKD","LU2750360997.AUD","LU0345770993.USD","LU2471134952.CNY","IE0034235188.USD","BK4516","LU2471134523.USD","LU2471134879.HKD","IE0004086264.USD","BK4552","LU1804176565.USD","LU0106831901.USD","BK4127","BK4533","IE00BSNM7G36.USD","LU1868836914.USD","LU0251142724.SGD","LU2237443465.HKD","LU1868837136.USD","LU0345770308.USD","BK4139","BK4532","LU0942090050.USD","IE0002270589.USD","LU0251131958.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637355342","title":"Exelixis EVP Commercial Patrick J. Haley sells 32,110 shares for $1.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2637355342","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637355342?lang=en_us&edition=fundamental","pubTime":"2026-05-23 05:02","pubTimestamp":1779483735,"startTime":"0","endTime":"0","summary":"Exelixis EVP, Commercial Patrick J. Haley sold 32,110 common shares on May 20, 2026 at an average price of USD 49.81.Haley held 357,638 shares following the sale, according to the filing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL8Cjmn0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Exelixis EVP Commercial Patrick J. Haley sells 32,110 shares for $1.6 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4532","EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637352760","title":"Exelixis to present Cabometyx, zanzalintinib studies at ASCO annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2637352760","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637352760?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:00","pubTimestamp":1779397235,"startTime":"0","endTime":"0","summary":"Exelixis will present data on cabozantinib and investigational zanzalintinib at the 2026 American Society of Clinical Oncology Annual Meeting, May 29 to June 2, in Chicago.Key readouts include new analyses from the phase 3 CABINET trial for cabozantinib, with additional results from the phase 3 STELLAR-303 trial evaluating zanzalintinib in metastatic colorectal cancer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via Business Wire  on May 21, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL1KD1pD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","EXEL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637358480","title":"How Investors May Respond To Exelixis (EXEL) Merck MRD+ Colorectal Cancer Trial Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2637358480","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637358480?lang=en_us&edition=fundamental","pubTime":"2026-05-21 23:45","pubTimestamp":1779378307,"startTime":"0","endTime":"0","summary":"Earlier in May 2026, Exelixis announced a clinical development collaboration with Merck, under which Exelixis will sponsor the planned phase 3 STELLAR-316 trial testing its investigational kinase inhibitor zanzalintinib with and without Merck’s subcutaneous KEYTRUDA QLEX in resected stage II/III colorectal cancer patients who are molecular residual disease–positive after definitive therapy.\nThe partnership, which also incorporates Natera’s Signatera assay to identify eligible MRD+ patients,...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/how-investors-may-respond-to-exelixis-exel-merck-mrd-colorec","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/how-investors-may-respond-to-exelixis-exel-merck-mrd-colorec","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2324357040.USD","LU2491050154.USD","LU1934455194.USD","SG9999002224.SGD","LU1066051811.HKD","BK4211","LU0965508806.USD","LU0106261372.USD","EXEL","SG9999002232.USD","LU2125154935.USD","LU1093756168.USD","BK4588","MRK","LU0861579265.USD","LU2461242641.AUD","LU0208291251.USD","LU1291159041.SGD","LU2106854487.HKD","LU0203345920.USD","LU1037948897.HKD","IE00BLSP4452.SGD","LU0859254822.USD","LU0211331839.USD","IE00BSNM7G36.USD","LU0965509010.AUD","LU1116320737.USD","LU2361044949.HKD","LU2468319806.SGD","LU0130517989.USD","LU2125909247.SGD","LU0265550946.USD","SGXZ57979304.SGD","LU1037948541.HKD","SG9999001440.SGD","SG9999014567.USD","LU1430594728.SGD","LU1066051498.USD","IE0009355771.USD","BK4559","LU0006306889.USD","LU1917777945.USD","LU1162221912.USD","LU0130102774.USD","LU1699723380.USD","LU0238689110.USD","LU1061106388.HKD","LU1093756325.SGD","IE00BBT3K403.USD","LU0432979614.USD","SG9999001176.USD","LU0868494617.USD","LU1974910355.USD","SG9999014575.USD","LU1983299246.USD","LU0265550359.USD","SG9999015341.SGD","LU0320765646.SGD","LU1929549753.HKD","LU2491050071.SGD","LU1941712348.USD","LU1057294990.SGD","LU1934455863.HKD","LU2125154778.USD","BK4532","LU1023059063.AUD","LU0942090050.USD","LU0098860793.USD","IE00BN8TJ469.HKD","IE000M9KFDE8.USD","SG9999014559.SGD","LU2089984988.USD","IE00B4R5TH58.HKD","LU1035773651.USD","LU1116320901.HKD","LU1585245621.USD","LU2357627491.SGD","LU1989772923.USD","LU0868494708.USD","LU2361045086.USD","BK4550","LU2112291526.USD","LU0320765489.SGD","LU1069347547.HKD","LU2023250843.SGD","LU1201861249.SGD","LU0070302665.USD","BK4585","LU1066051225.USD","LU0122379950.USD","LU0289739699.SGD","LU1934455277.USD","LU1941712264.USD","LU2433249047.HKD","BK4534","IE00B2B36J28.USD","LU2361044865.SGD","BK4516","SG9999001176.SGD","LU1923622614.USD","IE0002141913.USD","BK4139","LU0648001328.SGD","LU0980610538.SGD","LU1989772840.SGD","LU1066053197.SGD","LU1571399168.USD","SG9999013999.USD","LU0965509101.SGD","IE00B1BXHZ80.USD","LU0234572021.USD","IE00BFTCPJ56.SGD","LU0203347892.USD","LU0058720904.USD","LU2125909593.SGD","IE00BLSP4239.USD","LU0985320562.USD","LU0266013472.USD","BK4007","SG9999015358.SGD","IE00BJJMRZ35.SGD","BK4533","LU1989771016.USD","LU2023250504.SGD","LU2360032135.SGD","SG9999014542.SGD","LU0965509283.SGD","LU0477156953.USD","LU2491049909.HKD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636891974","title":"Top Exelixis Executive Cashes In on Major Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2636891974","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636891974?lang=en_us&edition=fundamental","pubTime":"2026-05-20 10:16","pubTimestamp":1779243362,"startTime":"0","endTime":"0","summary":"New insider activity at Exelixis ( ($EXEL) ) has taken place on May 19, 2026. Exelixis has reported a notable insider transaction as EVP & CFO Chri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-exelixis-executive-cashes-in-on-major-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-exelixis-executive-cashes-in-on-major-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","EXEL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636686041","title":"Exelixis EVP, CFO Christopher Senner disposes 75,793 shares for $3.78 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2636686041","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636686041?lang=en_us&edition=fundamental","pubTime":"2026-05-20 06:59","pubTimestamp":1779231557,"startTime":"0","endTime":"0","summary":"Exelixis EVP and CFO Christopher J. Senner disposed of 75,793 common shares in transactions dated May 15 and May 18.40,892 shares were withheld at USD 51.1 to cover taxes tied to RSU vesting.Senner also sold 34,901 shares at a weighted average price of USD 50.Directly held common shares fell to 952,317 following the transactions.He also reported 2,723 shares held indirectly through a 401 plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 19, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL4BM6jX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Exelixis EVP, CFO Christopher Senner disposes 75,793 shares for $3.78 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4532","EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636415860","title":"Exelixis SVP, General Counsel Brenda Hefti disposes 13,036 shares worth $662,202.55","url":"https://stock-news.laohu8.com/highlight/detail?id=2636415860","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636415860?lang=en_us&edition=fundamental","pubTime":"2026-05-20 06:59","pubTimestamp":1779231549,"startTime":"0","endTime":"0","summary":"Exelixis SVP and General Counsel Brenda Hefti reported a reduction in her common stock stake through share dispositions in mid-May.Sold 6,625 shares on May 18 at a weighted average price of $50.21.Withheld 6,411 shares on May 15 at $51.1 to cover taxes tied to RSU vesting.Reported direct ownership of 106,762 shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 19, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL5P4Rm9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4532","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636185964","title":"Merck to Collaborate With Exelixis on Phase 3 Colorectal Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2636185964","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636185964?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:50","pubTimestamp":1779195006,"startTime":"0","endTime":"0","summary":"Merck  has signed an agreement with Exelixis  to supply it with the Keytruda QLEX injection for a phase 3 trial in patients with resected stage 2/3 colorectal cancer, Exelixis said Tuesday.The trial will evaluate Exelixis' zanzalintinib oral kinase inhibitor in combination with and without Keytruda QLEX in patients who, following definitive therapy, have tested positive for molecular residual disease and have no radiographic evidence of disease, Exelixis said.The primary endpoint of the trial will be disease-free survival, with key secondary endpoints including circulating tumor DNA clearance, the company said.Exelixis added that the trial is expected to commence in mid-2026.Exelixis shares were up 1.4% in Tuesday's premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1116320901.HKD","SG9999002232.USD","LU0289739699.SGD","LU0265550946.USD","SG9999013999.USD","IE00BLSP4452.SGD","MRK","LU1037948541.HKD","LU0942090050.USD","LU0265550359.USD","IE00BJT1NW94.SGD","BK4007","BK4532","LU0203347892.USD","LU1989772923.USD","LU0058720904.USD","LU2433249047.HKD","LU2324357040.USD","LU2125154778.USD","LU0965509101.SGD","BK4533","LU1571399168.USD","LU2023250843.SGD","LU0130102774.USD","IE000M9KFDE8.USD","SG9999015341.SGD","LU0868494708.USD","LU2089984988.USD","LU1923622614.USD","IE00BFTCPJ56.SGD","LU0648001328.SGD","LU0320765646.SGD","LU1430594728.SGD","LU0965509283.SGD","LU1057294990.SGD","SG9999001176.USD","LU2106854487.HKD","LU0266013472.USD","LU0859254822.USD","LU0211331839.USD","LU2468319806.SGD","LU1035773651.USD","LU0477156953.USD","LU1989772840.SGD","LU2125909247.SGD","SG9999014542.SGD","LU2491049909.HKD","LU1093756168.USD","SG9999002224.SGD","LU0965509010.AUD","BK4559","SG9999001176.SGD","LU2023250504.SGD","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU2491050154.USD","LU2357627491.SGD","SG9999014567.USD","LU0868494617.USD","LU2125909593.SGD","SG9999014559.SGD","LU2491050071.SGD","LU0070302665.USD","LU1934455863.HKD","LU1066051811.HKD","LU1291159041.SGD","LU1941712264.USD","SGXZ57979304.SGD","IE00BSNM7G36.USD","IE00BBT3K403.USD","LU0106261372.USD","IE00B1BXHZ80.USD","LU1974910355.USD","LU1066053197.SGD","LU0130517989.USD","LU1917777945.USD","LU0861579265.USD","BK4516","LU2360032135.SGD","LU0208291251.USD","IE0002141913.USD","LU0965508806.USD","LU1093756325.SGD","IE00B4R5TH58.HKD","LU1934455277.USD","LU1116320737.USD","LU0238689110.USD","BK4550","LU1061106388.HKD","LU2361045086.USD","LU1929549753.HKD","LU2125154935.USD","LU0320765489.SGD","LU1037948897.HKD","LU1585245621.USD","LU0006306889.USD","LU0432979614.USD","LU0122379950.USD","LU1699723380.USD","LU1941712348.USD","BK4588","IE00BN8TJ469.HKD","LU2461242641.AUD","LU1162221912.USD","SG9999015358.SGD","BK4534","LU1069347547.HKD","LU0203345920.USD","LU1023059063.AUD","LU1934455194.USD","EXEL","BK4585","SG9999014575.USD","LU1983299246.USD","BK4139","LU1066051225.USD","IE00BLSP4239.USD","LU1066051498.USD","LU1201861249.SGD","LU0234572021.USD","LU2112291526.USD","LU2361044865.SGD","LU0098860793.USD","LU0980610538.SGD","LU1989771016.USD","LU0985320562.USD","LU2361044949.HKD","IE0009355771.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636855775","title":"Exelixis partners with Merck on phase 3 colorectal cancer trial combining zanzalintinib, Keytruda Qlex","url":"https://stock-news.laohu8.com/highlight/detail?id=2636855775","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636855775?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:07","pubTimestamp":1779192445,"startTime":"0","endTime":"0","summary":"Exelixis entered a clinical development collaboration with Merck for the planned Phase 3 STELLAR-316 pivotal trial in resected stage II/III colorectal cancer.Merck will supply KEYTRUDA QLEX  for subcutaneous use in combination with zanzalintinib.Exelixis will sponsor STELLAR-316, which will test zanzalintinib with or without KEYTRUDA QLEX in patients who are molecular residual disease-positive with no radiographic evidence of disease.The primary endpoint is disease-free survival, with circulating tumor DNA clearance as a key secondary endpoint.Exelixis expects to start the trial in mid-2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL4rYWfC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765646.SGD","LU0868494617.USD","MRK","IE000M9KFDE8.USD","LU2125154778.USD","LU2361044949.HKD","LU0203345920.USD","LU0211331839.USD","SG9999015358.SGD","LU1093756325.SGD","LU1917777945.USD","LU1057294990.SGD","LU0265550946.USD","LU0965509283.SGD","LU0859254822.USD","BK4588","SG9999014567.USD","LU2125909247.SGD","LU0965508806.USD","LU2112291526.USD","SG9999015341.SGD","LU2491049909.HKD","SG9999002224.SGD","LU1974910355.USD","LU0320765489.SGD","BK4516","IE00BLSP4239.USD","LU1066051225.USD","LU0965509101.SGD","LU2023250843.SGD","SG9999001440.SGD","LU0942090050.USD","LU1699723380.USD","LU0098860793.USD","SG9999001176.SGD","BK4533","LU0130102774.USD","LU1093756168.USD","LU1934455277.USD","IE00BN8TJ469.HKD","IE00BFTCPJ56.SGD","LU0868494708.USD","LU0106261372.USD","SGXZ57979304.SGD","LU0432979614.USD","IE00B1BXHZ80.USD","LU0266013472.USD","LU1934455863.HKD","SG9999001176.USD","LU1989772923.USD","IE00BJJMRZ35.SGD","IE00BSNM7G36.USD","IE0002141913.USD","LU1291159041.SGD","LU1023059063.AUD","LU1066053197.SGD","LU1037948541.HKD","LU2361045086.USD","LU0006306889.USD","LU1061106388.HKD","LU1430594728.SGD","LU2360032135.SGD","IE00B4R5TH58.HKD","LU1929549753.HKD","LU1066051498.USD","LU2491050071.SGD","SG9999014542.SGD","BK4550","LU1585245621.USD","LU0289739699.SGD","SG9999013999.USD","LU2491050154.USD","IE00BJT1NW94.SGD","IE00BLSP4452.SGD","LU2106854487.HKD","LU2125154935.USD","SG9999014575.USD","LU0861579265.USD","LU1066051811.HKD","LU2357627491.SGD","BK4559","LU0203347892.USD","BK4585","LU2125909593.SGD","LU0130517989.USD","LU0985320562.USD","LU0238689110.USD","IE0009355771.USD","LU1162221912.USD","SG9999014559.SGD","LU2468319806.SGD","LU0965509010.AUD","BK4534","LU0058720904.USD","LU2461242641.AUD","LU2433249047.HKD","LU1983299246.USD","LU0980610538.SGD","LU1571399168.USD","LU1035773651.USD","LU1069347547.HKD","LU2361044865.SGD","BK4139","LU0208291251.USD","BK4007","EXEL","LU0477156953.USD","LU2023250504.SGD","LU0234572021.USD","LU2324357040.USD","LU1934455194.USD","IE00B2B36J28.USD","LU1201861249.SGD","LU1989772840.SGD","LU1941712264.USD","IE00BBT3K403.USD","LU1037948897.HKD","LU2089984988.USD","BK4532","LU0070302665.USD","LU0648001328.SGD","LU1989771016.USD","LU0122379950.USD","LU0265550359.USD","LU1941712348.USD","LU1116320901.HKD","LU1116320737.USD","LU1923622614.USD","SG9999002232.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636855998","title":"Exelixis Inc - Expects to Initiate Stellar-316 in Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2636855998","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636855998?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:00","pubTimestamp":1779192004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUA3G6C13:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","BK4139","EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636785599","title":"Exelixis Inc - Merck to Supply Keytruda Qlex for Stellar-316 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2636785599","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636785599?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:00","pubTimestamp":1779192004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUA3G6C13:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4532","EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636559688","title":"Exelixis Announces Clinical Development Collaboration With Merck for Phase 3 Stellar-316 Pivotal Trial for Patients With Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2636559688","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636559688?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:00","pubTimestamp":1779192004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUA3G6C13:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EXEL","BK4139","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636070193","title":"Exelixis Advances Zanzalintinib Into Phase 2 Meningioma Trial, Signaling Pipeline Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2636070193","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636070193?lang=en_us&edition=fundamental","pubTime":"2026-05-19 00:31","pubTimestamp":1779121870,"startTime":"0","endTime":"0","summary":"Exelixis ($EXEL) announced an update on their ongoing clinical study. Exelixis has launched a new Phase 2 trial called “A Phase 2, Single-Arm, Mult...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/exelixis-advances-zanzalintinib-into-phase-2-meningioma-trial-signaling-pipeline-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/exelixis-advances-zanzalintinib-into-phase-2-meningioma-trial-signaling-pipeline-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EXEL","BK4532","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":5,"totalSize":144,"code":"91000000","status":"200"}]}}